These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 28377795)
1. Crosstalk between Tryptophan Metabolism and Cardiovascular Disease, Mechanisms, and Therapeutic Implications. Liu G; Chen S; Zhong J; Teng K; Yin Y Oxid Med Cell Longev; 2017; 2017():1602074. PubMed ID: 28377795 [TBL] [Abstract][Full Text] [Related]
2. Genetic Deficiency of Indoleamine 2,3-dioxygenase Aggravates Vascular but Not Liver Disease in a Nonalcoholic Steatohepatitis and Atherosclerosis Comorbidity Model. Arora A; Tripodi GL; Kareinen I; Berg M; Forteza MJ; Gisterå A; Griepke S; Casagrande FB; Martins JO; Abdalla DSP; Cole J; Monaco C; Ketelhuth DFJ Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563591 [TBL] [Abstract][Full Text] [Related]
3. Tryptophan Metabolism in Obesity: The Indoleamine 2,3-Dioxygenase-1 Activity and Therapeutic Options. Engin AB; Engin A Adv Exp Med Biol; 2024; 1460():629-655. PubMed ID: 39287867 [TBL] [Abstract][Full Text] [Related]
4. IDO1 promotes CSFV replication by mediating tryptophan metabolism to inhibit NF-κB signaling. Zhao F; Huang Y; Ji J; Liu X; Li X; Zou L; Wu K; Liu Xd; Zeng S; Wang X; Hu W; Song Y; Lu Z; Zhou B; Li P; Wang W; Zhao M; Chen J; Yi L; Fan S J Virol; 2024 Jul; 98(7):e0045824. PubMed ID: 38814067 [TBL] [Abstract][Full Text] [Related]
5. The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis. Baumgartner R; Forteza MJ; Ketelhuth DFJ Cytokine; 2019 Oct; 122():154148. PubMed ID: 28899580 [TBL] [Abstract][Full Text] [Related]
6. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases. Song P; Ramprasath T; Wang H; Zou MH Cell Mol Life Sci; 2017 Aug; 74(16):2899-2916. PubMed ID: 28314892 [TBL] [Abstract][Full Text] [Related]
7. Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation. Wang Q; Liu D; Song P; Zou MH Front Biosci (Landmark Ed); 2015 Jun; 20(7):1116-43. PubMed ID: 25961549 [TBL] [Abstract][Full Text] [Related]
8. Enhanced tryptophan-kynurenine metabolism via indoleamine 2,3-dioxygenase 1 induction in dermatomyositis. Wu D; Chen M; Chen S; Zhang S; Chen Y; Zhao Q; Xue K; Xue F; Chen X; Zhou M; Li H; Zheng J; Le Y; Cao H Clin Rheumatol; 2022 Oct; 41(10):3107-3117. PubMed ID: 35778590 [TBL] [Abstract][Full Text] [Related]
9. The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. An emerging field. Polyzos KA; Ketelhuth DF Hamostaseologie; 2015; 35(2):128-36. PubMed ID: 25599530 [TBL] [Abstract][Full Text] [Related]
10. Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice. Aslamkhan AG; Xu Q; Loughlin A; Vu H; Pacchione S; Bhatt B; Garfinkel I; Styring TG; LaFranco-Scheuch L; Pearson K; Reynolds S; Li N; Zhou H; Miller JR; Solban N; Bass A; Glaab WE Toxicol Appl Pharmacol; 2020 Nov; 406():115216. PubMed ID: 32871117 [TBL] [Abstract][Full Text] [Related]
11. Quantification of IDO1 enzyme activity in normal and malignant tissues. Zhai L; Ladomersky E; Bell A; Dussold C; Cardoza K; Qian J; Lauing KL; Wainwright DA Methods Enzymol; 2019; 629():235-256. PubMed ID: 31727243 [TBL] [Abstract][Full Text] [Related]
12. Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity. Mondanelli G; Albini E; Orecchini E; Pallotta MT; Belladonna ML; Ricci G; Grohmann U; Orabona C Front Immunol; 2021; 12():713989. PubMed ID: 34394118 [TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease. Mazarei G; Leavitt BR J Huntingtons Dis; 2015; 4(2):109-18. PubMed ID: 26397892 [TBL] [Abstract][Full Text] [Related]
14. Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process. Salminen A Ageing Res Rev; 2022 Mar; 75():101573. PubMed ID: 35085834 [TBL] [Abstract][Full Text] [Related]
15. Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease. Mazarei G; Budac DP; Lu G; Adomat H; Tomlinson Guns ES; Möller T; Leavitt BR J Neurochem; 2013 Dec; 127(6):852-67. PubMed ID: 23786539 [TBL] [Abstract][Full Text] [Related]
16. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO. Kim M; Tomek P Front Immunol; 2021; 12():636081. PubMed ID: 33708223 [TBL] [Abstract][Full Text] [Related]
17. Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia Atene CG; Fiorcari S; Mesini N; Alboni S; Martinelli S; Maccaferri M; Leonardi G; Potenza L; Luppi M; Maffei R; Marasca R Front Immunol; 2022; 13():832263. PubMed ID: 35371054 [TBL] [Abstract][Full Text] [Related]
18. A peripheral blood mononuclear cell-based in vitro model: A tool to explore indoleamine 2, 3-dioxygenase-1 (IDO1). Gonçalves M; Furgiuele A; Rasini E; Legnaro M; Ferrari M; Luini A; Rodrigues-Santos P; Caramelo F; Marino F; Pereira FC; Cosentino M Eur J Pharmacol; 2024 Apr; 968():176420. PubMed ID: 38367683 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice. Polyzos KA; Ovchinnikova O; Berg M; Baumgartner R; Agardh H; Pirault J; Gisterå A; Assinger A; Laguna-Fernandez A; Bäck M; Hansson GK; Ketelhuth DF Cardiovasc Res; 2015 May; 106(2):295-302. PubMed ID: 25750192 [TBL] [Abstract][Full Text] [Related]
20. Tryptophan and its metabolites in normal physiology and cancer etiology. Perez-Castro L; Garcia R; Venkateswaran N; Barnes S; Conacci-Sorrell M FEBS J; 2023 Jan; 290(1):7-27. PubMed ID: 34687129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]